TCL Archive Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness July 26, 2013
TCL Archive Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival October 29, 2010
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
